Clinical Data Repository

SARC has established a vast repository of clinical data sets which includes essential clinical trial data acquired over the years from our researchers and collaborators. This data is now available to sarcoma researchers for further study.

Female with glasses looking at computer screen

Available Inventory

The SARC Clinical Data Repository inventory includes data sets from 12 clinical trials, including more than 1,700 patients with various subtypes of sarcoma.

SARC001
Phase II Trial of Imatinib Mesylate in Bone and Soft Tissue Sarcoma

SARC002
Phase III Trial of Gemcitabine v. Gemcitabine Plus Docetaxel in Soft Tissue Sarcoma

SARC003
Phase II Trial of Gemcitabine and Docetaxel in Osteosarcoma, Ewing sarcoma, Chondrosarcoma

SARC004
Phase II Trial of Gemcitabine and Docetaxel in Uterine Leiomyosarcoma

SARC005
Phase II Trial of Adriamycin/ifosfamide and Adriamycin/etoposide in MPNST

SARC006
Phase II Trial of Adriamycin/ifosfamide and Adriamycin/etoposide in MPNST

SARC007
Phase II Trial of Perifosine in Chemo-Insensitive Sarcomas

SARC009
Phase II Trial of Dasatinib in Advanced Sarcomas

SARC016
Phase II Trial of Everolimus With Bevacizumab in MPNST

SARC018 – SPORE 01
Phase II Trial of Mocetinostat and Gemcitabine in Metastatic Leiomyosarcoma

SARC020
Phase II/III Trial of Doxorubicin Hydrochloride or Trabectedin in Metastatic Soft Tissue Sarcoma

SARC021
Phase III Trial of TH-302 with or without Doxorubicin in Soft Tissue Sarcoma

SARC028
Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients with Advanced Sarcomas
 

Using the Data Sets

Have an idea for a study that calls for SARC clinical data? We’d like to know about it. Please contact us at sarc-uds@sarctrials.org for details on using our data. We will provide email confirmation once your information has been received.

Back to top